Nifty
Sensex
:
:
22198.35
73095.22
76.30 (0.34%)
305.09 (0.42%)

Pesticides & Agrochemicals

Rating :
44/99

BSE: 532851 | NSE: INSECTICID

541.55
26-Feb-2024
  • Open
  • High
  • Low
  • Previous Close
  •  543.90
  •  559.00
  •  529.60
  •  541.15
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  96665
  •  523.51
  •  727.00
  •  414.05

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,604.50
  • 24.57
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,764.56
  • 0.55%
  • 1.58

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 72.16%
  • 2.73%
  • 10.39%
  • FII
  • DII
  • Others
  • 4.41%
  • 8.79%
  • 1.52%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.62
  • 8.58
  • 8.25

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 4.07
  • -8.22
  • -4.36

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 4.66
  • -12.38
  • -12.36

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 15.89
  • 13.89
  • 15.97

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.06
  • 1.64
  • 1.71

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.69
  • 9.29
  • 10.39

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Mar 23
Mar 22
Var%
Net Sales
357.94
356.53
0.40%
695.99
582.21
19.54%
639.95
560.69
14.14%
301.90
277.98
8.60%
Expenses
331.93
333.28
-0.41%
614.06
513.75
19.53%
594.31
502.24
18.33%
330.18
244.14
35.24%
EBITDA
26.01
23.26
11.82%
81.93
68.45
19.69%
45.65
58.45
-21.90%
-28.28
33.84
-
EBIDTM
7.27%
6.52%
11.77%
11.76%
7.13%
10.43%
-9.37%
12.18%
Other Income
1.22
0.37
229.73%
-0.17
0.28
-
3.89
0.19
1,947.37%
0.41
2.09
-80.38%
Interest
2.79
4.84
-42.36%
2.86
2.74
4.38%
3.17
1.41
124.82%
4.47
1.06
321.70%
Depreciation
7.42
6.43
15.40%
7.35
6.40
14.84%
6.88
6.62
3.93%
6.65
6.78
-1.92%
PBT
17.02
12.36
37.70%
71.55
59.60
20.05%
39.49
50.61
-21.97%
-38.98
28.09
-
Tax
4.77
3.08
54.87%
18.60
14.94
24.50%
10.46
12.62
-17.12%
-10.02
5.70
-
PAT
12.26
9.28
32.11%
52.95
44.66
18.56%
29.03
38.00
-23.61%
-28.96
22.39
-
PATM
3.42%
2.60%
7.61%
7.67%
4.54%
6.78%
-9.59%
8.05%
EPS
4.16
3.16
31.65%
17.96
15.15
18.55%
9.85
12.94
-23.88%
-9.90
7.55
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 09
Net Sales
1,995.78
1,801.33
1,503.96
1,420.23
1,363.22
1,193.51
1,073.25
994.21
988.24
965.21
263.70
Net Sales Growth
12.29%
19.77%
5.90%
4.18%
14.22%
11.21%
7.95%
0.60%
2.39%
266.03%
 
Cost Of Goods Sold
1,543.80
1,274.94
1,007.38
974.23
936.87
725.85
694.22
669.94
608.52
583.65
153.00
Gross Profit
451.98
526.39
496.58
445.99
426.35
467.66
379.03
324.27
379.72
381.56
110.70
GP Margin
22.65%
29.22%
33.02%
31.40%
31.28%
39.18%
35.32%
32.62%
38.42%
39.53%
41.98%
Total Expenditure
1,870.48
1,679.44
1,334.28
1,267.89
1,207.36
1,006.34
925.43
882.84
896.25
854.20
236.92
Power & Fuel Cost
-
36.08
30.30
22.43
23.34
18.37
14.08
13.72
11.96
15.05
0.85
% Of Sales
-
2.00%
2.01%
1.58%
1.71%
1.54%
1.31%
1.38%
1.21%
1.56%
0.32%
Employee Cost
-
98.38
86.65
76.51
74.74
65.19
50.62
45.51
40.75
35.11
5.84
% Of Sales
-
5.46%
5.76%
5.39%
5.48%
5.46%
4.72%
4.58%
4.12%
3.64%
2.21%
Manufacturing Exp.
-
181.88
157.55
148.02
120.79
145.08
116.04
114.98
78.30
78.47
32.12
% Of Sales
-
10.10%
10.48%
10.42%
8.86%
12.16%
10.81%
11.56%
7.92%
8.13%
12.18%
General & Admin Exp.
-
31.41
25.40
20.69
24.02
25.58
20.74
20.41
20.10
15.71
4.99
% Of Sales
-
1.74%
1.69%
1.46%
1.76%
2.14%
1.93%
2.05%
2.03%
1.63%
1.89%
Selling & Distn. Exp.
-
38.01
15.14
15.94
12.60
13.58
21.65
11.35
134.37
125.00
38.24
% Of Sales
-
2.11%
1.01%
1.12%
0.92%
1.14%
2.02%
1.14%
13.60%
12.95%
14.50%
Miscellaneous Exp.
-
18.74
11.87
10.07
14.99
12.69
8.08
6.93
2.25
1.21
38.24
% Of Sales
-
1.04%
0.79%
0.71%
1.10%
1.06%
0.75%
0.70%
0.23%
0.13%
0.71%
EBITDA
125.31
121.89
169.68
152.34
155.86
187.17
147.82
111.37
91.99
111.01
26.78
EBITDA Margin
6.28%
6.77%
11.28%
10.73%
11.43%
15.68%
13.77%
11.20%
9.31%
11.50%
10.16%
Other Income
5.35
1.26
4.27
7.73
2.57
0.74
3.24
6.83
0.75
0.65
1.46
Interest
13.29
13.45
6.63
6.65
23.89
15.22
15.92
20.23
25.94
33.18
2.82
Depreciation
28.30
26.10
26.35
24.67
24.07
19.68
17.05
16.00
16.46
14.61
1.12
PBT
89.08
83.60
140.97
128.74
110.46
153.01
118.10
81.97
50.34
63.87
24.31
Tax
23.81
20.62
33.94
25.60
24.42
30.60
34.12
22.57
10.76
9.03
3.42
Tax Rate
26.73%
24.67%
24.08%
21.51%
22.11%
20.00%
28.89%
27.53%
21.37%
14.14%
14.05%
PAT
65.28
63.21
107.43
93.90
86.04
122.41
83.97
59.40
39.58
54.84
20.91
PAT before Minority Interest
65.28
63.21
107.43
93.90
86.04
122.41
83.97
59.40
39.58
54.84
20.91
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
3.27%
3.51%
7.14%
6.61%
6.31%
10.26%
7.82%
5.97%
4.01%
5.68%
7.93%
PAT Growth
-42.90%
-41.16%
14.41%
9.14%
-29.71%
45.78%
41.36%
50.08%
-27.83%
162.27%
 
EPS
22.05
21.35
36.29
31.72
29.07
41.35
28.37
20.07
13.37
18.53
7.06

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 09
Shareholder's Funds
918.29
869.61
820.38
731.73
662.00
547.84
464.49
408.55
290.76
101.01
Share Capital
29.60
19.73
20.67
20.67
20.67
20.67
20.67
20.67
12.68
12.68
Total Reserves
888.69
849.88
799.71
711.06
641.34
527.17
443.82
387.88
278.08
88.33
Non-Current Liabilities
39.75
54.81
52.59
45.97
52.82
53.02
41.85
52.40
73.53
15.20
Secured Loans
1.86
1.85
2.40
1.91
1.32
8.28
15.17
28.05
53.66
13.71
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.25
0.00
0.00
0.09
Long Term Provisions
23.07
37.63
34.30
23.63
33.63
25.89
17.51
1.44
0.65
0.00
Current Liabilities
759.51
507.79
584.52
539.31
673.61
424.78
489.00
475.46
556.01
85.22
Trade Payables
448.27
323.79
362.03
246.56
279.87
243.36
198.68
211.11
209.98
44.58
Other Current Liabilities
153.80
136.22
128.12
106.69
97.23
84.36
83.51
83.56
78.37
30.21
Short Term Borrowings
154.97
45.64
91.61
183.48
295.17
96.76
205.96
152.59
240.95
0.00
Short Term Provisions
2.48
2.15
2.75
2.58
1.34
0.29
0.85
28.20
26.71
10.43
Total Liabilities
1,717.55
1,432.21
1,457.49
1,317.01
1,388.43
1,025.64
995.34
936.41
920.30
201.43
Net Block
261.73
252.98
238.80
239.10
240.20
231.57
184.59
198.46
204.71
24.59
Gross Block
402.11
369.97
336.70
313.75
292.04
264.34
200.47
247.96
238.23
27.46
Accumulated Depreciation
140.38
116.99
97.90
74.65
51.84
32.77
15.88
49.51
33.52
2.87
Non Current Assets
485.34
429.48
371.40
338.68
326.00
306.14
280.18
260.23
256.49
42.41
Capital Work in Progress
123.06
90.98
58.65
38.96
19.00
16.82
58.18
51.23
42.61
0.75
Non Current Investment
16.93
15.55
13.55
11.89
12.49
16.51
10.98
3.14
3.14
17.07
Long Term Loans & Adv.
82.26
68.59
59.92
48.13
54.02
40.90
25.92
7.17
6.00
0.00
Other Non Current Assets
0.49
1.38
0.48
0.59
0.30
0.34
0.50
0.24
0.00
0.00
Current Assets
1,232.21
1,002.74
1,086.08
978.33
1,062.43
719.49
715.17
674.92
661.62
155.31
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
861.72
630.22
660.87
519.26
705.11
407.29
425.78
350.60
391.40
96.34
Sundry Debtors
296.24
288.91
254.59
319.79
244.25
234.81
211.61
207.73
166.81
33.15
Cash & Bank
19.69
36.14
83.29
74.16
9.24
20.11
9.22
12.11
8.61
3.36
Other Current Assets
54.55
4.19
8.07
7.38
103.83
57.28
68.55
104.47
94.80
22.46
Short Term Loans & Adv.
49.96
43.27
79.26
57.74
97.97
52.54
62.54
97.70
89.91
9.70
Net Current Assets
472.69
494.95
501.57
439.02
388.82
294.72
226.16
199.46
105.61
70.08
Total Assets
1,717.55
1,432.22
1,457.48
1,317.01
1,388.43
1,025.63
995.35
936.40
920.30
201.44

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 09
Cash From Operating Activity
-10.63
134.85
155.36
241.85
-133.13
181.54
4.01
85.88
-5.53
6.29
PBT
83.83
141.37
119.50
111.33
153.41
118.10
81.97
50.34
63.87
24.34
Adjustment
37.49
36.05
29.41
47.54
37.25
31.71
38.00
36.96
38.29
4.05
Changes in Working Capital
-101.32
-2.01
33.70
115.09
-292.01
57.98
-98.92
12.58
-99.66
-15.06
Cash after chg. in Working capital
20.00
175.41
182.62
273.96
-101.34
207.79
21.05
99.88
2.51
13.33
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-4.21
Tax Paid
-30.63
-40.56
-27.26
-32.10
-31.79
-26.25
-17.04
-13.66
-7.15
-2.84
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-0.34
-0.89
0.00
Cash From Investing Activity
-86.40
9.31
-112.60
-24.09
-48.99
-25.82
-13.64
-18.70
-34.27
-3.77
Net Fixed Assets
-64.20
-65.60
-42.64
-41.67
-29.88
-22.51
34.81
-17.62
-247.70
-6.08
Net Investments
-2.30
-1.58
-1.17
1.43
4.43
-5.21
0.04
0.00
6.08
1.21
Others
-19.90
76.49
-68.79
16.15
-23.54
1.90
-48.49
-1.08
207.35
1.10
Cash from Financing Activity
79.68
-114.64
-104.03
-158.97
171.50
-143.00
9.36
-63.68
36.04
-3.47
Net Cash Inflow / Outflow
-17.35
29.52
-61.27
58.79
-10.62
12.71
-0.27
3.50
-3.77
-0.96
Opening Cash & Equivalents
35.98
6.46
67.73
8.94
19.56
6.85
7.12
8.61
12.38
4.32
Closing Cash & Equivalent
18.63
35.98
6.46
67.73
8.94
19.56
6.85
12.11
8.61
3.36

Financial Ratios

Consolidated /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 09
Book Value (Rs.)
310.26
293.81
264.62
354.04
320.31
265.07
224.74
197.07
151.69
51.14
ROA
4.01%
7.44%
6.77%
6.36%
10.14%
8.31%
6.15%
4.26%
9.78%
11.51%
ROE
7.07%
12.71%
12.10%
12.35%
20.24%
16.59%
13.63%
11.34%
28.42%
23.70%
ROCE
9.75%
16.13%
13.74%
14.24%
20.65%
19.66%
15.55%
12.44%
26.91%
26.45%
Fixed Asset Turnover
5.14
4.67
4.88
4.99
4.70
5.25
4.80
4.31
7.77
11.98
Receivable days
53.79
60.07
66.07
68.11
66.86
66.83
71.11
65.22
35.35
40.03
Inventory Days
137.14
142.71
135.75
147.84
155.24
124.71
131.65
129.21
86.22
97.31
Payable days
110.52
124.25
114.01
94.42
78.25
91.00
83.31
88.37
50.26
63.34
Cash Conversion Cycle
80.42
78.54
87.81
121.54
143.85
100.54
119.45
106.07
71.31
74.00
Total Debt/Equity
0.17
0.06
0.12
0.26
0.46
0.21
0.51
0.51
1.11
0.14
Interest Cover
7.23
22.31
18.97
5.62
11.05
8.42
5.05
2.94
2.93
9.64

News Update:


  • Insecticides (India) gets patent for Novel Isoxazole Compound Or A Salt Thereof
    18th Dec 2023, 12:11 PM

    The said patent is for the term of 20 years from November 29, 2018 (Date of Filing)

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.